PHSA - BCC - PHARM - Hematologic Adverse Effects

After completing this course learners will be able to:

• Understand the pathophysiology of myelosuppression.
• Review the methods for grading myelosuppression.
• Describe the prevention, assessment and management of neutropenia and febrile neutropenia.
• Describe the prevention, assessment and management of thrombocytopenia.
• Describe the prevention, assessment and management of anemia.
• Describe the prevention, identification, and management of other hematologic side effects.
• Categorize cancer therapy agents commonly associated with hematologic toxicities.